Covered recipient · General Payments record
GEETANJALI KALE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$17,230.19
- Reported across 932 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,399.74 | 118 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $401.11 | 25 |
| Novo Nordisk AS | $335.28 | 22 |
| DEXCOM, INC. | $304.52 | 12 |
| MannKind Corporation | $171.71 | 9 |
| Amgen Inc. | $169.70 | 4 |
| SANOFI-AVENTIS U.S. LLC | $145.76 | 6 |
| RECORDATI_RARE_DISEASES_INC. | $132.06 | 5 |
| Antares Pharma, Inc. | $79.51 | 4 |
| Radius Health, Inc. | $75.77 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $70.67 | 3 |
| Alexion Pharmaceuticals, Inc. | $55.61 | 2 |
| ABBVIE INC. | $48.70 | 2 |
| Insulet Corporation | $48.33 | 2 |
| Corcept Therapeutics | $40.32 | 2 |
| Amneal Pharmaceuticals LLC | $33.71 | 2 |
| Abbott Laboratories | $31.89 | 2 |
| Ultragenyx Pharmaceutical Inc. | $29.12 | 1 |
| Esperion Therapeutics, Inc. | $27.59 | 2 |
| Kyowa Kirin, Inc. | $25.28 | 1 |
| Neurocrine BioSciences, Inc. | $25.06 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.78 | 1 |
| PFIZER INC. | $23.72 | 1 |
| CeQur Corporation | $21.80 | 1 |
| Alvogen Inc | $18.03 | 1 |
| VIVUS LLC | $16.44 | 1 |
| Tandem Diabetes Care, Inc. | $16.18 | 1 |
| Acella Pharmaceuticals, LLC | $13.90 | 1 |
| Medtronic, Inc. | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (118)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.